ASK REDCHAT ANYTHING ABOUT VISTAGEN THERAPEUTICS INC.
VistaGen Therapeutics Inc. (NASDAQ: VTGN)
Listen to this Section
$0.53
-0.0129
(
-2.37% )
419.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Fasedienol (PH94B)DetailsSocial Anxiety Disorder |
Phase 3 |
| Itruvone, PH10 (pherine nasal spray )DetailsMajor depressive disorder |
Phase 2b |
| PH80 ( nasal spray )DetailsMenopause, Hot flashes |
Phase 2b |
| Fasedienol (PH94B) (pherine nasal spray)DetailsAdjustment Disorder |
Phase 2a |
| AV-101(4-Cl-KYN) (targets the NMDAR)DetailsMajor depressive disorder |
Phase 2a |
| PH15 (pherine nasal spray)DetailsCognitive Dysfunction |
Phase 2a |
Market Data
|
| Open |
$0.53 |
| Previous Close |
$0.54 |
| Volume |
419.1K |
| Market Cap |
$21.55M |
| Day Range |
$0.53 - $0.58 |
| 52 Week Range |
$0.43 - $5.14 |
| Shares Outstanding |
39.62M |
| Change % |
-2.37% |
| Net Change |
▼ -0.0129 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2009 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-3,082,502.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-07-02 |
Sale |
-4854.00 |
Singh Shawn |
| 2024-07-02 |
Sale |
-4854.00 |
Adler Reid G. |
| 2024-07-02 |
Sale |
-2671.00 |
Prince Joshua S. |
| 2024-07-02 |
Sale |
-3592.00 |
Anderson Cynthia Lynn |
| 2024-06-26 |
Sale |
-170000.00 |
Adler Reid G. |
| 2024-06-26 |
Sale |
-150000.00 |
Prince Joshua S. |
| 2024-06-26 |
Sale |
-150000.00 |
Anderson Cynthia Lynn |
| 2024-06-26 |
Sale |
-500000.00 |
Singh Shawn |
| 2024-03-06 |
Sale |
-12500.00 |
FitzPatrick Margaret M |
| 2024-03-06 |
Sale |
-12500.00 |
Curley Joanne |